The ex-dividend date for Amgen (Nasdaq:AMGN) is tomorrow, November 13, 2012. Owners of shares as of market close today will be eligible for a dividend of 36 cents per share. At a price of $85.24 as of 9:30 a.m., the dividend yield is 1.7%.
Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model. NEW YORK ( TheStreet) -- The ex-dividend date for Amgen (Nasdaq: AMGN) is tomorrow, November 13, 2012. Owners of shares as of market close today will be eligible for a dividend of 36 cents per share. At a price of $85.24 as of 9:30 a.m. ET, the dividend yield is 1.7%. The average volume for Amgen has been 4.2 million shares per day over the past 30 days. Amgen has a market cap of $65.03 billion and is part of the health care sector and drugs industry. Shares are up 32.6% year to date as of the close of trading on Friday. Amgen Inc., a biotechnology medicines company, discovers, develops, manufactures, and markets human therapeutics based on advances in cellular and molecular biology for grievous illnesses primarily in the United States, Europe, and Canada. The company has a P/E ratio of 15.2, below the S&P 500 P/E ratio of 17.7.
EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
TheStreet Ratings rates Amgen as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, notable return on equity, reasonable valuation levels and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full Amgen Ratings Report. See our dividend calendar or top-yielding stocks list. FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!.